Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Asymptomatic 1

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Dynamic Contrast Enhanced Magnetic Resonance Imaging × Clear all
NCT01931709 2023-11-18

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

University of Washington

Phase NA Terminated
35 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡